Fundz

Histogenics Corp reported raising $30 Million in an initial SEC Form D filing, from an offering of $30 Million

PUBLIC · OCGNOct 12, 2016

Amount Raised

$30 Million

$30 Million sold, per SEC Form D (first sale Oct 12, 2016)

Round Type

Venture

MalvernBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Ocugen raised $30 Million in a funding round, dated October 12, 2016. Ocugen is based in Malvern, Pennsylvania, United States.

How much did Ocugen raise?
Ocugen raised $30 Million in a funding round on October 12, 2016.
What does Ocugen do?
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe.
Where is Ocugen based and how big is it?
Ocugen is based in Malvern, Pennsylvania, United States. Fundz records about 137 employees.
Who are the decision-makers at Ocugen?
Fundz holds 2 contacts at Ocugen, including the AVP, Manufacturering Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Ocugen that raised within 45 days of this round, from Fundz verified event records.

  • ShockWave Medical raised $45M on November 22, 2016.
  • BioCardia raised $36M on November 4, 2016.
  • TuHURA Biosciences raised an undisclosed amount on November 4, 2016.
  • Crispr Therapeutics raised $35M on November 4, 2016.
  • Galectin raised $1.5M (Seed) on September 28, 2016.
  • Cocrystal Pharma, Inc. raised $4M (Seed) on September 15, 2016.

Who to call at Ocugen, and when

A new round usually means Ocugen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ocugen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ocugen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ocugen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ocugen

Location

11 Great Valley Parkway

Malvern, Pennsylvania, United States

About

Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients’ lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ocugen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsEmily L., AVP, Manufacturering Operations hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ocugen's next move

See what Strategic adds

Ocugen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.